NICE 目前被低估,具备显著上行空间(DCF 公允价值 188 美元,对比股价 116 美元),但由于利润率与 ROIC 持续恶化,投资信心偏低。
逐段跳播
交易代码为 NICE,即 NICE 公司,正通过其领域扩张战略拓展业务,并以中高个位数的速度增长收入。AI 订单正在增加,他们积压的工作量也在增加。
Trading symbol NICE, the company " NICE", is expanding its business and growing its revenues at mid-to-high single-digit rates through its field expansion strategy. AI bookings are increasing , and so is the volume of backlogged work they have.
但在当前市场价格下,这只股票看起来像是一个买入机会吗?这就是我想在本视频中回答的问题:结合该公司最近的业绩和收入预测,以及其长期表现和盈利轨迹,并将其与估值进行比较,以判断它是否是一项有吸引力的投资。
But does this stock look like a buying opportunity at current market prices? This is the question I want to answer in this video by combining the company’s most recent performance and revenue forecasts with its long-term performance and earnings trajectory, and comparing that with its valuation to determine whether it makes an attractive investment.
在过去十年中,NICE 的收入从 10 亿美元增长到超过 30 亿美元,在此期间增长了两倍。
Over the past decade, NICE has increased its revenue from $1 billion to over $3 billion, tripling in that period.
管理层预计到 2028 年收入将达到 35 亿美元。据跟踪 NICE,或者说 Nice 的华尔街分析师称,我不确定它到底该怎么发音,你来告诉我。
Management expects revenues to reach $3.5 billion by 2028. According to Wall Street analysts who follow NICE, or "Nice", I don't know exactly how to pronounce it, you tell me.
他们认为,管理层对 2030 年收入达到 38 亿美元的预测略显保守。华尔街分析师实际上预计到 2028 年收入将达到 39 亿美元。
They believe that management's forecast of revenues reaching $3.8 billion in 2030 is a bit conservative. Wall Street analysts actually expect revenue to reach $3.9 billion by 2028.
预计未来几年收入增长将加速。2025 年业务增长了 7.7%,预计 2026 年增长 8.3%,2027 年增长 9%,2028 年增长 11.8%。
Revenue growth is expected to accelerate over the next few years . In 2025, business grew by 7.7%, and is projected to grow by 8.3% in 2026, 9% in 2027, and 11.8% in 2028.
所以,收入正在加速增长,管理层持乐观态度,而华尔街分析师实际上比管理层更乐观。当我查看该公司的经营性现金流与销售额之比时,首先想到的第一个警示信号。
So, revenues are accelerating, management is optimistic, and Wall Street analysts are actually more optimistic than management. The first warning sign that comes to mind when I look at the company's cash flow from operations to sales ratio.
在 2023 年至 2025 年间,该公司的经营性现金流与销售额之比有所上升,从 20% 升至 30% 以上。然而,这一数字在 2025 年至 2026 年间降至 20%。如今,近几个月来,它已达到一个转折点,并再次上升。
Between 2023 and 2025, the company increased its operating cash flow to sales ratio, rising from 20% to over 30%. However, this figure dropped to 20% between 2025 and 2026. Now, in recent months, it has reached a turning point and is rising again.
我略感担忧的是,该公司的收入在增长,但其利润率和经营性现金流与销售额之比却在下降。我在该公司的投入资本回报率中看到了类似的趋势,它已从约 15% 降至 10.8%。10.8% 这一数字低于平均水平,也低于该公司的加权平均资本成本。
在 2022 年至 2026 年间,投入资本回报率一直在上升,但在过去十年中,这一指标的改善并不一致。
I am slightly concerned that the company's revenue is increasing, but its profit margins and the ratio of cash flow from operations to sales are decreasing. I see a similar trend in the company’s return on invested capital, which has fallen from about 15% to 10.8%.
This figure of 10.8% is below average and below the company's weighted average cost of capital . Between 2022 and 2026, the return on invested capital was increasing, but over the past decade, there has been no consistency in improving this metric.
所以,这些就是我在 NICE 方面密切关注的事项。随着收入增长,我会监测利润率。中高个位数或低两位数的收入增长率是强劲的数字,但我希望看到这些数字至少伴随着稳定的利润率,也就是说利润率保持稳定或达到向更高水平转变的临界点。
So, these are the things I'm watching closely with regard to NICE. I monitor margins as revenues grow. Revenue growth rates in the mid-to- high single digits or low double digits are strong numbers, but I would like to see these numbers coupled with at least stable margins, meaning they remain steady or reach a tipping point towards higher levels.
鉴于这些对利润率的担忧,估值被认为相对便宜,我并不感到意外。基于预期市盈率,该股目前的交易倍数为 9.1。因此,对于一家预计未来几年收入增速将高于其预期盈利倍数的公司来说,这是一只相对便宜的股票。
Given these concerns about margins, I am not surprised that the valuation is considered relatively cheap. Based on the forward price-to-earnings ratio, the stock is trading at 9.1 .
Therefore, it is a relatively cheap stock for a company whose revenues are expected to grow over the next few years at a rate greater than its forward earnings multiple.
我还更新了我的贴现现金流估值模型,我并不预期该公司会有非常强劲的增长。2026 年,我估计自由现金流将下降至 6 亿,从那时起,到 2030 年将上升至 9.9 亿。也就是说,未来几年自由现金流将增长约 50% 或略多。
增幅并不大,尤其是考虑到预计未来几年收入将实现两位数增长。
I have also updated my discounted cash flow valuation model , and I do not expect very strong growth for the company. In 2026, I estimate free cash flow will decline to 600 million, and from that point onward, it will rise to 990 million by 2030.
That's an increase of about 50% or slightly more in free cash flow over the next few years. Not a huge increase, especially considering that revenue growth is expected to be in the double digits over the next few years.
尽管增长前景相对温和,该股似乎仍被低估。我用现金流折现模型计算出其合理价值为 188 美元,而当前市场价格为 116 美元。因此,按当前市场价格计算,我估计从这一水平还有 62% 的强劲上行空间。
Despite relatively modest growth prospects, the stock still appears to be undervalued . I calculated a fair value of $188 using a discounted cash flow model, while the current market price is $116.
Therefore, I estimate a strong upside of 62% from here, given current market prices.
无论我是使用远期市盈率倍数,还是使用现金流折现模型,这只股票似乎都被低估了。那么,来回答我在标题中提出的问题:我认为这是一个买入机会吗?我会说是的。
Regardless of whether I use a forward price-to-earnings multiple or a discounted cash flow model, this stock appears to be undervalued. So, to answer the question I posed in the title , do I think it's a buying opportunity? I will say yes.
不过,我也要说,我对这一评级信心不高、把握不大,而我已经解释了原因,那就是利润率。在营收增长接近两位数的情况下,我本希望看到利润率保持稳定或至少上升,但我看到的却恰恰相反。在我看到利润率企稳之前,我认为我不会抱有很高的信心。
However, I also say that I have a low conviction and a low level of confidence in this rating, and I have explained the reason, which is the margins. With revenue growth approaching double digits , I would have liked to see stable or at least increasing margins, but I am seeing the opposite.
Until I see that stability in the margins , I don't think I'll have a high level of confidence.
我会继续把这家公司作为可选机会之一加以关注,我们将会看到,也希望利润率在此时有所改善或企稳。
I will continue to monitor this company as one of the opportunities available, and we will see and hope that the margins improve or stabilize at this point.
观察点
这个频道对 $NICE 的历次判断
Parkev Tatevosian, CFA 在这只股票上只有这一条判断。